Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Fexofenadine Hydrochloride
by Most Research Publications in the world in 2022

The Fexofenadine Hydrochloride top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Research Publications Fexofenadine Hydrochloride Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and second generation, long-lasting selective histamine H1 receptor antagonist, with antihistaminic activity. Upon administration, fexofenadine competitively binds of peripheral H1-receptors in the gastrointestinal (GI) tract, blood vessels, and bronchial smooth muscle. This prevents binding of histamine to peripheral H1-receptors and prevents their activation. This prevents a histamine-mediated allergic reaction. Fexofenadine does not cross the blood-brain-barrier (BBB).
#
Company Name
Region
Tech Topics
Total
1
United Kingdom
Literature: 5
2
Ontario, Canada
Social network,Health care,Mental health,
...[+1]
Literature: 1
3
Sinai University
Arkansas, United States
Arabic,Chemistry,Medicine,
...[+2]
Literature: 1
4
Dr. Reddy's Laboratories, Inc.
North Carolina, United States
Drug,Biotechnology,Health care,
...[+2]
Literature: 1
5
Ontario, Canada
Health care,Health Insurance Portability and Accountability Act,Heart disease,
...[+2]
Literature: 1
Page generation time: Jul 22 2025